Research
Flagship analytical reports on AI-driven transformation in drug discovery, pharma, and healthcare — grounded in a decade of tracking this space.
AI Drug Discovery Pipeline Report 2026
Agents, Platforms, and Clinical Reality
The third annual edition of the most cited independent analysis of AI-discovered drug candidates. This edition expands coverage to agentic AI systems, large-scale virtual screening platforms, and the clinical-stage pipeline that separates real progress from hype.
Sponsorship InquiriesThe GLP-1 Revolution: Reshaping Pharma, Healthcare, and Beyond
A comprehensive analysis of how GLP-1 receptor agonists went from a diabetes treatment to a force reshaping pharmaceutical strategy, healthcare economics, insurance, and consumer behavior. First edition.
Sponsorship InquiriesPrevious Editions
Previously published through BiopharmaTrend.com
Past work has been cited by Deloitte, Forbes, RAND Corporation, the European Parliament, and the US Department of Energy, as well as published in numerous high impact scientific journals.
Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond
Updated landscape analysis of AI-driven drug discovery platforms, pipeline progression data, and the shift from legacy computational chemistry to modern AI-native approaches.
Read on BiopharmaTrend
It's Been a Decade of AI in the Drug Discovery Race. What's Next?
Comprehensive decade-in-review of AI-discovered drug candidates, target novelty analysis, and competitive landscape mapping across leading AI drug discovery platforms.
Read on BiopharmaTrendCustom Analytical Projects
I take on select projects at the intersection of AI, biotech, and pharma strategy — landscape analyses, industry trend briefings, and sponsored research tailored to specific business questions. If you need an independent analytical perspective grounded in a decade of tracking this space, let's talk.
Get in touch